vs
Forestar Group Inc.(FOR)与REPLIGEN CORP(RGEN)财务数据对比。点击上方公司名可切换其他公司
Forestar Group Inc.的季度营收约是REPLIGEN CORP的1.4倍($273.0M vs $197.9M),REPLIGEN CORP净利率更高(6.7% vs 5.6%,领先1.1%),REPLIGEN CORP同比增速更快(13.6% vs 9.0%),REPLIGEN CORP自由现金流更多($17.6M vs $-157.1M),过去两年REPLIGEN CORP的营收复合增速更高(14.4% vs -9.6%)
福雷斯特集团是一家住宅地块开发企业,总部位于得克萨斯州阿灵顿,业务覆盖美国21个州的51个市场。截至2020年12月31日的12个月内,该公司交付了11518块住宅地块,目前在纽约证券交易所上市,自2002年起就是美国规模最大的住宅建筑商D.R. Horton的控股子公司。
Repligen是一家全球生命科学企业,专注于创新生物工艺技术与系统的研发及商业化,助力提升生物药生产效率。公司1981年成立,总部位于美国马萨诸塞州沃尔瑟姆,于纳斯达克挂牌上市,股票代码RGEN,截至2025年全球员工超1900人,主要服务生物制药领域客户。
FOR vs RGEN — 直观对比
营收规模更大
FOR
是对方的1.4倍
$197.9M
营收增速更快
RGEN
高出4.6%
9.0%
净利率更高
RGEN
高出1.1%
5.6%
自由现金流更多
RGEN
多$174.7M
$-157.1M
两年增速更快
RGEN
近两年复合增速
-9.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $273.0M | $197.9M |
| 净利润 | $15.4M | $13.3M |
| 毛利率 | 20.1% | 52.5% |
| 营业利润率 | 7.6% | 9.0% |
| 净利率 | 5.6% | 6.7% |
| 营收同比 | 9.0% | 13.6% |
| 净利润同比 | -6.7% | 143.9% |
| 每股收益(稀释后) | $0.30 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FOR
RGEN
| Q4 25 | $273.0M | $197.9M | ||
| Q3 25 | $670.5M | $188.8M | ||
| Q2 25 | $390.5M | $182.4M | ||
| Q1 25 | $351.0M | $169.2M | ||
| Q4 24 | $250.4M | $174.1M | ||
| Q3 24 | $551.3M | $154.9M | ||
| Q2 24 | $318.4M | $154.1M | ||
| Q1 24 | $333.8M | $151.3M |
净利润
FOR
RGEN
| Q4 25 | $15.4M | $13.3M | ||
| Q3 25 | $86.9M | $14.9M | ||
| Q2 25 | $32.9M | $14.9M | ||
| Q1 25 | $31.6M | $5.8M | ||
| Q4 24 | $16.5M | $-30.3M | ||
| Q3 24 | $81.5M | $-654.0K | ||
| Q2 24 | $38.7M | $3.3M | ||
| Q1 24 | $45.0M | $2.1M |
毛利率
FOR
RGEN
| Q4 25 | 20.1% | 52.5% | ||
| Q3 25 | 22.3% | 53.2% | ||
| Q2 25 | 20.4% | 50.0% | ||
| Q1 25 | 22.6% | 53.6% | ||
| Q4 24 | 22.0% | 26.1% | ||
| Q3 24 | 23.9% | 50.0% | ||
| Q2 24 | 22.5% | 49.8% | ||
| Q1 24 | 24.9% | 49.5% |
营业利润率
FOR
RGEN
| Q4 25 | 7.6% | 9.0% | ||
| Q3 25 | 16.9% | 8.9% | ||
| Q2 25 | 11.2% | 7.6% | ||
| Q1 25 | 11.6% | 3.9% | ||
| Q4 24 | 8.7% | -17.7% | ||
| Q3 24 | 19.7% | -5.1% | ||
| Q2 24 | 16.2% | 1.0% | ||
| Q1 24 | 17.6% | 1.3% |
净利率
FOR
RGEN
| Q4 25 | 5.6% | 6.7% | ||
| Q3 25 | 13.0% | 7.9% | ||
| Q2 25 | 8.4% | 8.2% | ||
| Q1 25 | 9.0% | 3.4% | ||
| Q4 24 | 6.6% | -17.4% | ||
| Q3 24 | 14.8% | -0.4% | ||
| Q2 24 | 12.2% | 2.2% | ||
| Q1 24 | 13.5% | 1.4% |
每股收益(稀释后)
FOR
RGEN
| Q4 25 | $0.30 | $0.24 | ||
| Q3 25 | $1.70 | $0.26 | ||
| Q2 25 | $0.65 | $0.26 | ||
| Q1 25 | $0.62 | $0.10 | ||
| Q4 24 | $0.32 | $-0.55 | ||
| Q3 24 | $1.59 | $-0.01 | ||
| Q2 24 | $0.76 | $0.06 | ||
| Q1 24 | $0.89 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $211.7M | $767.6M |
| 总债务越低越好 | $793.2M | $542.2M |
| 股东权益账面价值 | $1.8B | $2.1B |
| 总资产 | $3.2B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.44× | 0.26× |
8季度趋势,按日历期对齐
现金及短期投资
FOR
RGEN
| Q4 25 | $211.7M | $767.6M | ||
| Q3 25 | $379.2M | $748.7M | ||
| Q2 25 | $189.2M | $708.9M | ||
| Q1 25 | $174.3M | $697.2M | ||
| Q4 24 | $132.0M | $757.4M | ||
| Q3 24 | $481.2M | $784.0M | ||
| Q2 24 | $359.2M | $809.1M | ||
| Q1 24 | $416.2M | $780.6M |
总债务
FOR
RGEN
| Q4 25 | $793.2M | $542.2M | ||
| Q3 25 | $802.7M | $537.9M | ||
| Q2 25 | $872.8M | — | ||
| Q1 25 | $872.5M | — | ||
| Q4 24 | $806.8M | $525.6M | ||
| Q3 24 | $706.4M | — | ||
| Q2 24 | $706.1M | — | ||
| Q1 24 | $705.7M | — |
股东权益
FOR
RGEN
| Q4 25 | $1.8B | $2.1B | ||
| Q3 25 | $1.8B | $2.1B | ||
| Q2 25 | $1.7B | $2.1B | ||
| Q1 25 | $1.6B | $2.0B | ||
| Q4 24 | $1.6B | $2.0B | ||
| Q3 24 | $1.6B | $2.0B | ||
| Q2 24 | $1.5B | $2.0B | ||
| Q1 24 | $1.5B | $2.0B |
总资产
FOR
RGEN
| Q4 25 | $3.2B | $2.9B | ||
| Q3 25 | $3.1B | $2.9B | ||
| Q2 25 | $3.1B | $2.9B | ||
| Q1 25 | $3.0B | $2.9B | ||
| Q4 24 | $3.0B | $2.8B | ||
| Q3 24 | $2.8B | $2.8B | ||
| Q2 24 | $2.7B | $2.9B | ||
| Q1 24 | $2.6B | $2.8B |
负债/权益比
FOR
RGEN
| Q4 25 | 0.44× | 0.26× | ||
| Q3 25 | 0.45× | 0.26× | ||
| Q2 25 | 0.52× | — | ||
| Q1 25 | 0.53× | — | ||
| Q4 24 | 0.50× | 0.27× | ||
| Q3 24 | 0.44× | — | ||
| Q2 24 | 0.47× | — | ||
| Q1 24 | 0.48× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-157.0M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-157.1M | $17.6M |
| 自由现金流率自由现金流/营收 | -57.5% | 8.9% |
| 资本支出强度资本支出/营收 | 0.0% | 4.1% |
| 现金转化率经营现金流/净利润 | -10.19× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $93.0M | $93.9M |
8季度趋势,按日历期对齐
经营现金流
FOR
RGEN
| Q4 25 | $-157.0M | $25.7M | ||
| Q3 25 | $256.3M | $48.1M | ||
| Q2 25 | $15.8M | $28.6M | ||
| Q1 25 | $-19.8M | $15.0M | ||
| Q4 24 | $-450.0M | $39.2M | ||
| Q3 24 | $119.2M | $49.3M | ||
| Q2 24 | $-61.7M | $42.2M | ||
| Q1 24 | $-59.2M | $44.7M |
自由现金流
FOR
RGEN
| Q4 25 | $-157.1M | $17.6M | ||
| Q3 25 | $255.6M | $43.4M | ||
| Q2 25 | $15.0M | $21.5M | ||
| Q1 25 | $-20.5M | $11.4M | ||
| Q4 24 | — | $33.6M | ||
| Q3 24 | $118.4M | $42.3M | ||
| Q2 24 | $-62.3M | $37.4M | ||
| Q1 24 | $-59.8M | $36.4M |
自由现金流率
FOR
RGEN
| Q4 25 | -57.5% | 8.9% | ||
| Q3 25 | 38.1% | 23.0% | ||
| Q2 25 | 3.8% | 11.8% | ||
| Q1 25 | -5.8% | 6.8% | ||
| Q4 24 | — | 19.3% | ||
| Q3 24 | 21.5% | 27.3% | ||
| Q2 24 | -19.6% | 24.3% | ||
| Q1 24 | -17.9% | 24.0% |
资本支出强度
FOR
RGEN
| Q4 25 | 0.0% | 4.1% | ||
| Q3 25 | 0.1% | 2.5% | ||
| Q2 25 | 0.2% | 3.9% | ||
| Q1 25 | 0.2% | 2.1% | ||
| Q4 24 | 0.0% | 3.2% | ||
| Q3 24 | 0.1% | 4.5% | ||
| Q2 24 | 0.2% | 3.1% | ||
| Q1 24 | 0.2% | 5.5% |
现金转化率
FOR
RGEN
| Q4 25 | -10.19× | 1.93× | ||
| Q3 25 | 2.95× | 3.23× | ||
| Q2 25 | 0.48× | 1.92× | ||
| Q1 25 | -0.63× | 2.57× | ||
| Q4 24 | -27.27× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -1.59× | 12.70× | ||
| Q1 24 | -1.32× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
RGEN
暂无分部数据